PS3 KEYNOTE-024 Update: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC with PD-L1 Tumor Proportion Score ≥50%

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第9期|共1页
• 作者

  J. Brahmer; D. Rodríguez-Abreu; A. Robinson; R. Hui; T. Cs?szi; A. Fül?p; M. Gottfried; N. Peled; A. Tafreshi; S. Cuffe; M. OBrien; S. Rao; K. Hotta; A. Riccio; J. Yang; M.C. Pietanza; M. Reck;

  展开▼
• 作者单位

  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

  Hospital Universitario Insular de Gran Canaria;

  Cancer Centre of Southeastern Ontario at Kingston General Hospital;

  Westmead Hospital and the University of Sydney;

  Jász-Nagykun-Szolnok County Hospital;

  Országos Korányi Pulmonológiai Intézet;

  Meir Medical Center;

  Clalit Health Services Soroka Medical Center;

  Southern Medical Day Care Centre;

  St. James’s Hospital and Cancer Trials Ireland (formerly ICORG – All Ireland Cooperative Oncology;

  The Royal Marsden Hospital;

  MedStar Franklin Square Hospital;

  Okayama University Hospital;

  Merck &

  Co. Inc;

  Merck &

  Co. Inc;

  Merck &

  Co. Inc;

  LungenClinic Airway Research Center North German Center for Lung Research;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词